MagicTouch
Commercial- Indications
- Coronary artery disease, Peripheral artery disease, In-stent restenosis
Company intelligence / Profile preview
Concept Medical
Tampa, Florida, United Statesconceptmedical.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
Concept Medical’s MagicTouch Sirolimus Coated Balloon has demonstrated non-inferiority to paclitaxel-coated balloons in the SIRONA RCT for femoropopliteal PAD, with positive results presented at TCT USA 2024. The company is running multiple pivotal IDE trials in the US and has treated over a million patients globally with its technologies[3][5].
- Therapeutic areas
- CardiovascularNephrology
- Modalities
- DeviceNanoparticle (nanocarrier-based drug delivery)Drug-coated balloonDrug-eluting stentSmall molecule (sirolimus, paclitaxel)
- Industry
- Surgical Medical Devices
02
Drug pipeline
2 assets1 more asset in the full pipeline.
Beyond the preview
Go deeper on Concept Medical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Concept Medical.